By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The global smart feeding tube market is witnessing significant advancements in the healthcare industry. Smart feeding tubes, also known as enteral feeding tubes, have evolved to provide enhanced patient care and management. These tubes are used for delivering essential nutrients and medications directly to the stomach or small intestine when patients are unable to eat by mouth.
The market is experiencing growth due to an increasing elderly population, rising chronic illnesses, and a growing awareness of enteral nutrition.
Smart feeding tubes incorporate advanced technologies such as real-time monitoring, data analysis, and connectivity to improve patient outcomes and streamline healthcare processes.
Smart feeding tubes find application in hospitals, long-term care facilities, and home care, providing a wide range of options for healthcare professionals and patients.
Data from smart feeding tubes can be integrated into electronic health records (EHRs), enabling healthcare professionals to make informed decisions and improve patient care.
The market’s focus is shifting towards patient-centered care, with an emphasis on improving the overall experience of patients receiving enteral nutrition.
When they are unable to consume food or liquids safely by mouth, tube feeding is a technique to keep them nourished. If they are unconscious or having difficulty swallowing, this may occur. Tube feeding can deliver fluids and medications in addition to nourishment.
The contents of the stomach can also be removed using it. Gavage, enteral feeding, or tube feeding are terms for this.
Enteral nutrition has several benefits over parenteral feeding, including safety, efficacy, reduced risk of infection, lower cost, prevention of gut atrophy, and preservation of the gut’s barrier function. Most of the time, it is not painful, and many people eventually get used to it.
The Global Smart feeding tube Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The Entarik Feeding Tube System and Feeding Tube, developed by Gravitas Medical Inc., have received FDA approval, marking a significant milestone in the field of enteral nutrition. This innovative system includes a monitor and a sensor-equipped nasogastric tube, providing caregivers with valuable enteral nutrition insights to make informed decisions, thereby improving patient outcomes and reducing complications.
The FDA has granted FDA 510(k) clearance for the Entarik Feeding Tube System and Feeding Tube, signifying a breakthrough in enteral nutrition delivery. Gravitas Medical plans to introduce a series of products that will revolutionize enteral feeding by incorporating intelligence.
This development represents the initial phase of their mission to utilize technology to replace existing nutrition delivery methods with an enteral nutrition intelligence platform that empowers caregivers to make swift decisions for their patients.
The system consists of a “smart” nasogastric tube equipped with sensors to monitor its position relative to the stomach, accompanied by a monitor that continuously tracks the tube’s position during feeding.
By providing real-time alerts for tube movement, the device helps reduce the risk of misplacement during initial positioning, a critical concern since tube migration from the stomach to the esophagus can pose risks to patients.
The Entarik System is designed to notify ICU clinical staff promptly when a nasogastric tube shifts, enabling them to take immediate action to prevent complications.
